Target intelligence / Profile preview

ZIP8 (Zinc transporter ZIP8) (ZIP8)

Target
ZIP8
Molecular classification
Transporter, Solute carrier family, Divalent metal ion transporter
01

Overview

ZIP8, encoded by the SLC39A8 gene, is a divalent metal ion transporter highly expressed in hepatocytes and critical for the uptake and homeostatic regulation of manganese. It is localized to canalicular (apical) membranes in hepatocytes, enabling the reclamation of manganese from bile and controlling systemic manganese availability. Loss-of-function mutations in ZIP8 cause profound manganese deficiency, protein glycosylation disorders, and broad metabolic disturbances. Hepatic ZIP8 plays central roles in the activity of manganese-dependent enzymes (notably arginase and glycosyltransferases) that impact numerous physiological functions. Secondary transporters, such as ZIP14 and ZnT10, also contribute to hepatic Mn uptake and efflux, but ZIP8 has a key regulatory role in hepatocyte manganese import, especially during enterohepatic circulation. The term "Hepatocyte manganese uptake transport" should be replaced by the name of a defined transporter, most notably ZIP8/SLC39A8, for structured data representation.

Other names
SLC39A8 (gene name)Zinc transporter ZIP8ZIP-8
02

Mechanism of action

Restoration or inhibition of ZIP8 function alters cellular and systemic manganese (and zinc) levels, impacting the activity of Mn-dependent enzymes and global metabolic/physiological functions.

03

Biological functions

Manganese uptake into hepatocytesZinc uptakeRegulation of whole-body manganese homeostasisModulation of manganese-dependent enzyme activity (e.g., arginase, \u03b2-1,4-galactosyltransferase)Protein N-glycosylation
04

Disease associations

Inherited manganese deficiency (due to SLC39A8 mutations)Congenital disorders of glycosylation (via impaired Mn-dependent glycosyltransferase activity)Metabolic syndrome traitsPotential impact in neurodegenerative disease (via Mn handling)Other metal homeostasis disorders (e.g., iron, zinc-related)
05

Safety considerations

Manganese toxicity if homeostasis is not properly regulatedPotential off-target effects on other metal and metabolic homeostasis pathwaysUnintended consequences on glycosylation
06

Interacting drugs

No approved drugs directly targeting ZIP8

2 more in the full profile.

07

Biomarkers

Blood/tissue manganese concentrationGlycosylation pattern of plasma proteinsGenotype of SLC39A8 (e.g., rs13107325 variant)

Beyond the preview

Go deeper on ZIP8 (Zinc transporter ZIP8) (ZIP8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZIP8 (Zinc transporter ZIP8) (ZIP8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call